New Times,
New Thinking.

  1. World
3 July 2015

A Mexican parliamentarian proposed an anti-meme law – so the internet turned her into one

Hey dawg, we heard you don't like memes, so we turned you into a meme so you can oppose memes while being a meme.

By Media Mole

Pity Selma Guadalupe Gomez. The Mexican parliamentarian tried to introduce a law banning people from making memes, with a $1,600 fine attached.

As Fusion explains:

The ponderously titled “Law of Civil Responsibility for the Protection of the Right to Private Life, Honor and the Image of the State of Sonora” is more succinctly known as the “anti-meme” law. It calls for fines up to around $1,600, or 350 times the minimum wage in Hermosillo, the capital of Sonora, for creating and publishing memes that inflict “unjustified damage to human dignity.”

The internet, in a move that will surprise nobody, responded by creating memes of Congresswoman Gomez.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

“Memes no / deal with it”. Photo: via Make a Meme

 

Seriously, type her name into google images.

“Wants to regulate memes / is turned into one”. Photo: via memegenerator.es

 

Ironically, if the law were in place, this could have added substantially to the government coffers. Oportunidad perdida.

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines